Drug intelligence / Profile preview

RU79072

Development stage: Unknown
Modality: Small Molecules

Overview

RU79072 is a synthetic small molecule belonging to the class of organic compounds known as quinolines and derivatives, characterized by a quinoline moiety[1][2]. Its chemical formula is C10H7N2O4P[2][3]. There is limited publicly available information regarding its mechanism of action, therapeutic indications, or clinical development. No approved medical uses or marketed formulations are reported for this compound. It appears in chemical and pharmacological databases as an experimental or investigational molecule with no established clinical application.

Beyond the preview

Go deeper on RU79072.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RU79072.

Explore the full profile